Coya Therapeutics (COYA) Other Non Operating Income (2022 - 2026)
Coya Therapeutics' Other Non Operating Income came in at $408,728 for Q2 2026, up 27.9% from $319,541 a year earlier but down 5.7% from the prior quarter.
Powered by 
Analysis
Coya Therapeutics (COYA) Other Non Operating Income (2022 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Coya Therapeutics reported Other Non Operating Income of $1.48 million, down 5.0% year-over-year; for FY2025, it was $1.33 million, down 19.2% from FY2024.
- Going back by year, Other Non Operating Income was $1.65 million in FY2024 (+157.9%), $639,365 in FY2023 (+904.1%), $63,673 in FY2022 and -$21,482 in FY2021.
- The five-year range for quarterly Other Non Operating Income is -$3,017 (Q1 2022) to $444,232 (Q4 2024).
- Year-over-year, Other Non Operating Income increased in four of the last eight quarters, with growth averaging 40.9%.
- The fastest year-over-year change in Other Non Operating Income over five years came in Q4 2023 (growth of 969.6%), and the weakest in Q4 2025 (a decline of 26.7%).
- Business Quant data shows COYA's Other Non Operating Income at $433,227 (Q1 2026), $325,435 (Q4 2025) and $317,066 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Coya Therapeutics | 97.12 Mn | -71.76 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 408,728.00 |
| Mar 31, 2026 | 433,227.00 |
| Dec 31, 2025 | 325,435.00 |
| Sep 30, 2025 | 317,066.00 |
| Jun 30, 2025 | 319,541.00 |
| Mar 31, 2025 | 370,165.00 |
| Dec 31, 2024 | 444,232.00 |
| Sep 30, 2024 | 428,871.00 |
| Jun 30, 2024 | 344,445.00 |
| Mar 31, 2024 | 431,089.00 |
| Dec 31, 2023 | 174,672.00 |
| Sep 30, 2023 | 142,089.00 |
| Jun 30, 2023 | 158,970.00 |
| Mar 31, 2023 | 163,634.00 |
| Dec 31, 2022 | 16,330.00 |
| Sep 30, 2022 | 39,420.00 |
| Jun 30, 2022 | 10,940.00 |
| Mar 31, 2022 | -3,017.00 |
API Access
Coya Therapeutics Other Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=COYA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-operating-income", "ticker": "COYA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=COYA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();